On-demand webinars

Arrayjet webinars assume no prior knowledge and on-demand access will be available after each event.

Immunomics technologies using protein microarrays for biomarker research

Join Andreas Weinhausel from the Austrian Institute of Technology (AIT) and learn about the role of biomarkers in the clinical diagnosis and therapeutic treatment of rheumatoid arthritis.

Antibodies and autoantibodies make suitable biomarkers for the prediction and monitoring of disease. Sero-testing of plasma or serum is minimally invasive, and immunomics analysis has great potential for the diagnostics of autoimmune, cancerous, cardiologic, neurodegenerative, and systemic conditions.

Andreas is a biotechnologist and associate professor for molecular biology at the University of Natural Resources and Applied Life Sciences, Vienna. He has been at the Molecular Diagnostics business unit at AIT since 2004, specialising in DNA-methylation and autoantibody biomarker development high throughput technologies. This new workflow combines microarray and bead array technologies for biomarker development. Probing antigenic proteins and peptides, the platform offers a powerful solution for diagnosing cancer and autoimmune disease.

Register to watch on-demand

What is a microarray? And why you should care.

Arrayjet is delighted to be joined by partners Innopsys and Grace Bio-Labs for a free educational webinar.

Tune in to gain three specialist industry insights on how the latest microarray technology could help achieve your research goals.  Ideal whether you are new to the technique, or an experienced scientist looking for a refresher.

• Understand what microarrays are and how they are made
• Review examples of how they are used across biopharma, diagnostics, and research
• Hear about the slides, reagents and other tools required to perform a microarray
• Learn about fluorescence detection and how you can quantify fluorescent images of your microarray

Adam Buckle - Lab Manager at Arrayjet Ltd.
Shawna Prange - Director Of Research Development at Grace Bio-Labs
Adriana Lagraulet - Applications Manager at Innopsys

Register to watch on-demand

Protein Microarrays for Systematical Deciphering of SARS-CoV-2 Specific Humoral Immune Responses

Arrayjet welcomed Sheng-ce Tao from Shanghai Jiao Tong University.  The Tao Lab have constructed a SARS-CoV-2 protein microarray and analysed the antibody responses of >1000 COVID-19 patients.  They generated a comprehensive antibody response (IgG and IgM) landscape and have identified potential biomarkers for predicting the severity and outcome of the patients.

Furthermore, this landscape will facilitate our understanding of SARS-CoV-2-specific humoral responses and might be useful for vaccine refinement.

Multi-pronged functional proteomics approaches for biomarker discovery in chronic and infectious diseases

Arrayjet welcomed Manuel Fuentes from Centro de Investigación del Cáncer (IBMCC-FICUS) to discuss how protein microarrays are proving crucial in biomarker discovery.  Manuel was joined by Angela-Patricia Hernandez, Pablo Juanes-Velasco, and Alicia Landeira-Viñuela.

The team has extensive experience in developing protein microarrays in many formats and with different samples in order to deepen the understanding of biomarkers in chronic illness, cancer, and infectious disease.

Carbohydrate Microarray and Novel Glycoprofiling Applications

Combining the high-throughput capacity of car­bo­hydrate microarray with the specificity of monoclonal antibodies has potential across many applications.

William George Tycho Willats from N8 AgriFood, and Silvia Vidal Melgosa from Max Planck Institute for Marine Microbiology, demonstrated ways to determine substrate specificity of carbohydrate-active enzymes, and how the same principle can be used to screen other enzymes types, such as proteases.

Seromics: Decoding the Antibody Fingerprint

Each individual carries a 'fingerprint' of antibodies that describes a lifetime of immune experiences to foods, allergens, viruses, the microbiome, and other exposures. This fingerprint is exceptionally unique to each individual and can remain stable for decades - but what does it mean?

In this talk, CDI's director of Biomarker Development Tyler Hulett, PhD, will discuss the potential importance of anti-viral and autoantibody seromics technologies - what we already know about the antibody fingerprint - and what we still don't know - using example data from SARS-CoV-2, cancer, and autoimmune patients.

High-Density Protein Arrays and Affinity Proteomics

Arrayjet welcomes Ronald Sjöberg and August Jernbom Falk from the KTH affinity proteomics group at the SciLifeLab in Stockholm to discuss the high-density protein array developed by the Peter Nilsson group. 

Ronald heads up the Autoimmunity Profiling facility and supported by the Human Protein Atlas offers proteome-wide screening for autoantibody reactivity, epitope mapping, and antibody validation.

August talks about autoantibody profiling in psychiatric disorders.